Pharmed Pharmaceuticals Pty Ltd has acquired Amalgamated Pharmaceuticals Ltd
Pharmed Pharmaceuticals (Pty) Ltd (Pharmed) has acquired the business assets (excluding debtors and liabilities) of Amalgamated Pharmaceuticals Ltd (Amalgamated), a pharmaceutical wholesale and distribution company, for an undisclosed consideration.
Pharmed is a supplier and distributor of healthcare related products, including ethical, generic, patent, homeopathic, surgical, dental and veterinary products and medical equipment, reagents and supplies to dispensing doctors, retail pharmacies, private hospitals and other allied healthcare professionals. The acquisition of the Amalgamated business meets Pharmed’s strategic growth objective.
Amalgamated was formed in 1997 by the merger of five major pharmaceutical distribution companies, which boasted a track record of more than 60 years’ service. Amalgamated is a full-line, nation-wide wholesaler that is focused exclusively on the pharmaceutical market with its head office in Johannesburg and a satellite office in Durban.
Oaklins' team in South Africa acted as financial advisor to Pharmed in this transaction.
Talk to the deal team
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more